Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis

Thromb Res. 1999 Jan 1;93(1):9-16. doi: 10.1016/s0049-3848(98)00149-2.

Abstract

The antithrombotic effects of dietary lipids were investigated in rat models of arterial and venous thrombosis. In the arterial model, thrombus formation was evaluated by determination of the occlusion time and the deposition of 111In-labeled platelets and 125I-labeled fibrinogen in a collagen-coated glass capillary inserted into an arterio-arterial shunt. Venous thrombosis was evaluated by measurement of the thrombus weight after administration of thromboplastin as a source of tissue factor and establishment of stasis in the vena cava. Diets were supplemented with saturated (SAT group) or (n-3) fatty acids, the latter being added either as MaxEPA oil (MaxEPA group), or as docosahexaenoic (DHA group) or eicosapentaenoic (EPA group) ethyl ester. Only the MaxEPA group displayed a prolonged occlusion time as compared with all other groups. Platelet accumulation, similar in the MaxEPA, EPA and DHA groups (13.3, 16.7 and 17.7 x 10(6) platelets/shunt, respectively), was significantly higher in the SAT group (25.3 x 10(6) platelets/shunt), while accumulation of fibrinogen-fibrin was similar whatever the group. There was a trend towards a lower venous thrombus weight in MaxEPA fed rats relative to those fed other diets. Our data indicate that the MaxEPA diet had antithrombotic effects in arterial and to a lesser extent venous thrombosis models, best attributed to its multiple targeting of platelets and coagulation.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Docosahexaenoic Acids / therapeutic use
  • Eicosapentaenoic Acid / therapeutic use
  • Fatty Acids, Omega-3 / therapeutic use*
  • Fibrinogen / metabolism
  • Fibrinolytic Agents / therapeutic use*
  • Male
  • Platelet Count
  • Rats
  • Rats, Wistar
  • Thrombosis / drug therapy*
  • Venous Thrombosis / drug therapy*

Substances

  • Fatty Acids, Omega-3
  • Fibrinolytic Agents
  • Docosahexaenoic Acids
  • Fibrinogen
  • Eicosapentaenoic Acid